Status:

WITHDRAWN

Effect of Neurotization on QoL and Sensory Restoration

Lead Sponsor:

University of Wisconsin, Madison

Conditions:

Breast Reconstruction

Neurotization

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

This is a single-site, randomized, double-blinded trial to assess whether neurotization following autologous breast reconstruction in patients with breast cancer increases quality of life and sensatio...

Detailed Description

In 2019, nearly one third of cancers diagnosed in the United States were breast cancers. Per the Plastic Surgery procedural statistics from the American Society of Plastic Surgery database, that same ...

Eligibility Criteria

Inclusion

  • Willing to provide informed consent
  • The patient is ≥ 18 years
  • Patients presenting to UW Health who have had or will have unilateral or bilateral mastectomy (therapeutic or prophylactic) and are planning to undergo autologous reconstruction with TRAM/DIEP will be included

Exclusion

  • Patient is non-English speaking
  • Patient is known or believed to be pregnant
  • Patient is a minor (individuals \<18 years old)
  • Patient is a prisoner
  • Individuals unable to give consent due to another condition such as impaired decision-making capacity
  • Autologous reconstruction where the flap is buried (e.g. there is no autologous skin exposed for sensation testing)
  • Patient is a male
  • Any patient with: diabetic neuropathy, thyroid disorders, collagen vascular disease, alcoholism, pernicious anemia, or any other severe underlying peripheral neuropathy
  • Women with recurrent breast cancer
  • Women who have undergone previous breast reconstructive procedures
  • Not suitable for study participation due to other reasons at the discretion of the investigators
  • Patient is currently lactating
  • History of radiation therapy
  • Patient undergoing a latissimus dorsi flap for reconstruction
  • Patient undergoing alloplastic reconstruction

Key Trial Info

Start Date :

March 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2027

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT05206565

Start Date

March 1 2025

End Date

February 1 2027

Last Update

January 9 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.